This inventor holds 14 USPTO granted patents. Top assignees: United States of America, as Represented by the Secretary of Agriculture, The United States of America as Represented by the Secretary of. Active years: 1979-2014.
Company Filing History:
8 out of 1,215 
6 out of 2,202 
Years Active: 1979-2014
Title: The Innovator Behind Aquatic Vaccine Technologies: Phillip H. Klesius
Introduction
Phillip H. Klesius, a dedicated inventor based in Auburn, AL, has made significant contributions to the field of aquatic animal health. With an impressive tally of 14 patents to his name, Klesius has focused on developing innovative solutions to combat bacterial infections in aquatic species.
Latest Patents
Among his latest inventions are groundbreaking attenuated live vaccines designed specifically for aquatic animals. These vaccines, developed through the induction of novobiocin-resistance in liquid culture, provide safe and effective protection against bacteria infecting aquatic animals. Another notable patent features the creation of live vaccines for fish through the induction of rifampicin resistance in native isolates, including rifampicin-resistant mutants NRRL-B-50040 and NRRL-B-50041. This innovative approach utilizes single immersion exposure of fish to stimulate acquired immunity against virulent infections.
Career Highlights
Throughout his career, Phillip H. Klesius has collaborated with prominent organizations, notably including the United States of America, as represented by the Secretary of Agriculture. His work has advanced the understanding and treatment of infectious diseases in aquatic species, showcasing his commitment to improving animal health.
Collaborations
Klesius has had the pleasure of working alongside esteemed colleagues such as Craig A. Shoemaker and Joyce J. Evans. These collaborations have undoubtedly contributed to the successful development and implementation of his innovative vaccine technologies.
Conclusion
Phillip H. Klesius stands out as a key innovator in the domain of aquatic health, with a strong focus on developing effective vaccination strategies. His patents reflect a commitment to harnessing scientific research for practical applications, benefiting both aquatic animals and their caretakers. His continued contributions will likely lead to further advancements in the field and enhanced health management for aquatic species.